Back
Speaker illustration

Doctor Edita Pogran

Wilhelminen Hospital, Vienna (Austria)

Member of:

European Society of Cardiology

Edita Pogran is a cardiology resident at the 3 rd medical Department for Cardiology and Intensive Care Medicine in Clinic Ottakring, Vienna, Austria. She studied general medicine at the 3 rd medical faculty at Charles University in Prague. She is continuing her study at the Medical University in Vienna, where she is studying postgraduate program in Vascular Biology. Her research focuses mainly on hyperlipidemia, platelet function, Takotsubo Syndrome, and myocardial infarction under the supervision of Prof. Kurt Huber. Furthermore, she is active as a lector at the Medical University in Vienna and Sigmund Freud Private University in Vienna.

Presentations

Takotsubo syndrome before and during Covid-19 pandemic in Austria. A retrospective cohort study.TOSCA-19

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Acute heart failure - epidemiology, prognosis, outcome 1

Access
Like
Thumbnail

Pilot study: The LIPL-PLATELET study postprandial LIPid paneLs and PLATELET activity in coronary heart disease after treatment with PCSK9-inhibitors

Event: ESC Preventive Cardiology 2023

Topic: Drug therapy

Session: Moderated ePoster 10

Access
Like
Thumbnail

The LIPL Study Postprandial lipid profile, inflammation and platelet activity in patients with chronic coronary syndrome

Event: ESC Preventive Cardiology 2023

Topic: Lipids, Other

Session: Moderated ePoster 10

Access
Like
Thumbnail

The LIPL study lipid panels and platelet activity in coronary heart disease

Event: ESC Congress 2022

Topic: Platelets, Haemostasis, Coagulation

Session: Novel biomarkers in cardiovascular disease

Access
Like
Thumbnail

Long-term outcome in patients with Takotsubo syndrome: a single-center study from a city in Austria

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Access
Like
Thumbnail

Long-term mortality in TakoTsubo patients treated with different antiaggregation therapy

Event: Acute Cardiovascular Care 2019

Topic: Antiplatelet Drugs

Session: Cardiovascular Pharmacotherapy

Access
Like
Thumbnail

Impact of presence of nonsignificant coronary artery disease vs. completely normal angiogram on outcome in patients with Tako-Tsubo syndrome

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes: Tako-Tsubo Cardiomyopathy

Session: Organisation of Acute Coronary Sydrome care and MINOCA

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources